Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnosis and Treatment Monitoring of Native and Device-associated Meningitis Using D-lactate, a Pathogen-specific Diagnostic Biomarker in Cerebrospinal Fluid

NCT05146570 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.

NCT NCT05146570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05146570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnosis and Treatment Monitoring of Native and Device-associated Meningitis Using D-lactate, a Pathogen-specific Diagnostic Biomarker in Cerebrospinal Fluid
Lead sponsor
Charite University, Berlin, Germany
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2021
Completion date
May 31, 2024
Enrollment
842 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial meningitis, fungal meningitis, implant infection